Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:entinostat
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
209783-80-2
|
| gptkbp:chemicalFormula |
C21H20N4O3
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:Keryx_Biopharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
KRX-0401
|
| gptkbp:indication |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
histone deacetylase inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:HDAC3
gptkb:HDAC1 |
| gptkbp:bfsParent |
gptkb:Perifosine
|
| gptkbp:bfsLayer |
7
|